These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6123593)

  • 1. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
    Wong DT; Threlkeld PG; Best KL; Bymaster FP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):61-5. PubMed ID: 6123593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. McN-5652: a highly potent inhibitor of serotonin uptake.
    Shank RP; Vaught JL; Pelley KA; Setler PE; McComsey DF; Maryanoff BE
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1032-8. PubMed ID: 2905001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of binedaline, a new antidepressant drug.
    Morin D; Zini R; Urien S; Tillement JP
    J Pharmacol Exp Ther; 1989 Apr; 249(1):288-96. PubMed ID: 2540319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
    Raiteri M; Bonanno G; Marchi M; Maura G
    J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some biochemical properties of the new potential antidepressant agent N-methyl-N-propargyl-2-(1-methyl-5-methoxyindolyl)methylamine.
    Carranza Gómez-Carpintero M; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Sep; 43(9):937-41. PubMed ID: 8240453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
    Wong DT; Bymaster FP; Reid LR; Threlkeld PG
    Biochem Pharmacol; 1983 Apr; 32(7):1287-93. PubMed ID: 6303355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.
    Koe BK
    J Pharmacol Exp Ther; 1976 Dec; 199(3):649-61. PubMed ID: 994022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the serotonergic system in the mode of action of the new potential antidepressant agent 5-methoxyindolyl-2-methylamine.
    Carranza Gómez-Carpintero MC; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Aug; 43(8):809-13. PubMed ID: 8216432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug.
    Wong DT; Robertson DW; Bymaster FP; Krushinski JH; Reid LR
    Life Sci; 1988; 43(24):2049-57. PubMed ID: 2850421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
    Keller KJ; Elliott GR; Holman RB; Vernikos-Danellis J; Barchas JD
    J Pharmacol Exp Ther; 1976 Sep; 198(3):619-25. PubMed ID: 978463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism by tomoxetine of the depletion of norepinephrine and epinephrine in rat brain by alpha-methyl-m-tyrosine.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):169-72. PubMed ID: 6604933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H; Fonlupt P; Pacheco H
    C R Seances Soc Biol Fil; 1984; 178(1):38-44. PubMed ID: 6331605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.